Crossref
Metronomic Cyclophosphamide and Vinblastine in Refractory Lymphoma
Clinical Lymphoma and Myeloma · 2009-12 · 9 (6) · E33
DOI: 10.3816/clm.2009.n.095 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Lymphoma and Myeloma, 2009-12. Verfasst von Filip Geurs und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Geurs, F., Derveaux, L., & Verwimp, J. (2009). Metronomic Cyclophosphamide and Vinblastine in Refractory Lymphoma. Clinical Lymphoma and Myeloma, 9(6), E33. https://doi.org/10.3816/clm.2009.n.095
Vancouver
Geurs F, Derveaux L, Verwimp J. Metronomic Cyclophosphamide and Vinblastine in Refractory Lymphoma. Clinical Lymphoma and Myeloma. 2009;9(6):E33. doi:10.3816/clm.2009.n.095
BibTeX
@article{Geurs2009,
author = {Geurs, Filip and Derveaux, Luc and Verwimp, Jelke},
title = {Metronomic Cyclophosphamide and Vinblastine in Refractory Lymphoma},
journal = {Clinical Lymphoma and Myeloma},
year = {2009},
volume = {9},
number = {6},
pages = {E33},
doi = {10.3816/clm.2009.n.095}
}
EUVIMED